• 제목/요약/키워드: isostere

검색결과 12건 처리시간 0.026초

아드리아마이신의 유사제제 합성 (1) -안트라싸이클리논의 Isostere 로서 Tetrahydrobenzo(b)phenazine 유도체의 합성- (Synthesis of Adriamycin-related System (1) -Synthesis of the Derivative of Tetrahydrobenzo(b)phenazine as a Potential Isostere of Anthracyclinone-)

  • 장영동;장선영
    • 약학회지
    • /
    • 제34권4호
    • /
    • pp.219-223
    • /
    • 1990
  • 7,8-Dihydro-6,11-dihydroxy-9(10H)benzo(b)phenazinone was prepared from 1,2,3,4-tetra-hydrophenazine as a potential isostere of anthracyclinone. The attempts to functionalize at $C_9$ were not successful due to the unstability of the above ketone.

  • PDF

Binding Free Energy Simulations of the HIV-1 Protease and Hydroxyethylene Isostere Inhibitors

  • 원영도
    • Bulletin of the Korean Chemical Society
    • /
    • 제21권12호
    • /
    • pp.1207-1212
    • /
    • 2000
  • The free energy simulation technique is used to evaluate the relative binding affinity of a set of hydroxyethylene isostere inhibitors of the HIV-1 protease. The binding reactions and an alchemical mutation construct the thermodynamic cycle, which reduces the free energy difference of the binding interactions into that of the alchemical processes. In the alchemical process, a methyl group is mutated into a hydrogen atom. Albeit the change is a small perturbation to the inhibitor-protease complex, it results in 25 fold difference in the binding constants. The simulation reproduces the experimentally measured binding affinities within 2% of the free energy difference. The protonation state of the catalytic aspartic acid residues is also investigated through the free energy simulations.

ACE 억제제 합성 및 억제효과측정

  • 김병현;류은정
    • 한국응용약물학회:학술대회논문집
    • /
    • 한국응용약물학회 1994년도 춘계학술대회 and 제3회 신약개발 연구발표회
    • /
    • pp.219-219
    • /
    • 1994
  • 고혈압 치료제의 하나로 사용되고 있는 Angiotensin Converting Enzymc (ACE) 억제제를 본 실험실에서 개발한 $\alpha$-hydroxy ketomethylene isostere를 핵심요소로 하여 합성하였다. 합성한 억제제 후보물질의 억제효과는 Rabbit Ling으로 부터 단리된 ACE를 사용하여 분광학적인 방법에 의해 결정되었다. 화합물 1은 우수한 억제효과를 나타내었다.

  • PDF

4-(2'-(N-(1-메틸-3-(3'-카바밀페닐)-n-프로필))아미노에틸)-1-히드록시-2- 피리돈의 합성 (Synthesis of 4-(2'-(N-(1-methyl-3'-carbamylphenyl)-n-propyl))aminoethyl)-1-hydroxy-2-pyridone)

  • 윤성화
    • 약학회지
    • /
    • 제37권1호
    • /
    • pp.36-40
    • /
    • 1993
  • The 4-(2'-(N-(l-methyl-3'-carbamylphenyl)-n-propyl))aminoethyl)-l- hydroxy-2-pyridone which has isoelectronic and isosteric structural similarity with dobutamine without having the Catechol-O- Methyltransferase(COMT) vulnerable m-hydroxy group was synthesized via 12 synthetic steps.

  • PDF

해바라기 종실제품의 수분흡착열 (Heats of Moisture Adsorption for Sunflower Nutmeat Products)

  • 목철균;헤티아라치치 엔 에스
    • 한국식품과학회지
    • /
    • 제23권6호
    • /
    • pp.656-660
    • /
    • 1991
  • 해바라기 종실제품(종실, 착유박, 농축단백, 분리단백)의 수분흡착열을 $10,\;20,\;30^{\circ}C$에서 측정한 등습곡선(isostere)으로부터 구하였고, 수분함량에 따른 흡착열의 변화를 Hunter 방정식에 의거하여 해석하였다. Hunter 방정식에 의한 예측치는 실측결과와 잘 일치하였으며 단백질함량이 증가할수록 정확도가 높았다. 흡착열은 수분함량이 높을수록 감소하였으며, 단백질함량이 높을수록 증가하였다. 해바라기종실의 흡착열은 건물기준 수분함량 4-12%에서 11.8-10.6 kcal/mole이었으며 분리 단백의 경우 수분함량 6-20%에서 12.4-11.0kcal/mole 이었다.

  • PDF

Inhibition of HIV-1 Pretense by Novel Dipeptide Isosteres Containing 2-Isoxazoline or $\alpha$-Hydroxy Ketomethylene

  • Kim, Do-Hyung;Park, Kwan-Yong;Chung, Yong-Jun;Kim, Byeang-Hyean
    • Biomolecules & Therapeutics
    • /
    • 제2권2호
    • /
    • pp.155-160
    • /
    • 1994
  • Human immunodeficiency virus type 1 (HIV-1) protease is essential for the replication of the virus and it is therefore an attractive target for antiviral drugs of HIV-1. Several dipeptide isosteres containing 2-isoxazoline or $\alpha$-hydroxy ketomethylene have been synthesized and their inhibitory effects on the HIV-1 protease examined. The enzymatically active HIV-1 protease was purified to homogeniety from E. coli transformed with a recombinant plasmid (pMAL-pro) containing the entire gene encoding the protease. The purified protease had the substrate specificity with Km value of 9.8$\mu$M when an undecapeptide His-Lys-Ala-Arg-Val-Leu-(p-nitro)Phe-Glu-Ala-Nle-Ser-amide was used as a substrate, and the products from the substrate after specific cleavage by HIV-1 protease were analyzed by HPLC. The synthetic compounds containing dipeptide isosteres showed specific inhibitory effects while a dipeptide isostere containing an isoxazoline ring inhibited the HIV-1 protease competitively with Ki value of 500 $\mu$M. Even if the inhibition effects of HIV-1 protease were not very high, these novel dipeptide isosteres can be used as key structural moieties for developing specific inhibitors of HIV-1 protease.

  • PDF

5-(2'-(N-(1-메틸-3-(3'-카바밀페닐)-n-프로필))아미노에틸)-8-히드록시-4- 메틸카보스티릴 유도체의 합성 및 안정성 연구 (Synthesis and in Vitro Stability Evaluations of 5-(2'-(N-(1-methyl-3'-carbamylphenyl)-n-propyl))aminoethyl)-8-hydroxy-4-methylcarbostyril Derivatives)

  • 윤성화;박규순
    • 약학회지
    • /
    • 제39권5호
    • /
    • pp.506-510
    • /
    • 1995
  • The 5-(2'-(N-(1-methyl-3'-carbamylphenyl)-n-propyl))aminoethyl)-8- hydroxy-4-methyl-carbostyril derivatives which have isoelectronic and isosteric structural similarity with dobutamine without having the Catechol-O-Methyltransferase (COMT) vulnerable m-hydroxy group were synthesized via 7 synthetic steps, and their stabilities in phosphate buffer solution(pH=7.4), human blood. 80% human plasma and 20% rat liver homogenate were determined in vitro condition.

  • PDF

3-아미노-2-페닐이미노-1,3-티아졸린 유도체에 대한 Lipinski 법칙의 적용 및 그들의 합성 (Application of Lipinski Rule for 3-amino-2-phenylimino-1,3-thiazolines and Their Syntheses)

  • 박익규;한호규
    • 농약과학회지
    • /
    • 제10권2호
    • /
    • pp.69-75
    • /
    • 2006
  • 신농약 살균제 개발을 목표로 벼도열병균에 대한 살균활성이 있는 3-메틸-2-페닐이미노-1,3-티아졸린 유도체 1의 분자수정을 통하여 3-아미노-2-페닐이미노-1,3-티아졸린 유도체 2를 isostere의 개념을 근거 하에서 디자인하였다. 화합물 2는 모두 Lipinski 법칙에 따랐으며 가상계산에 의하면 물에 대한 용해도가 화합물 1보다 높았다. 티오우레아 4를 $\gamma$-클로로아세토아세트아닐라이드 유도체 5와 반응시켜 중간체 6H-[1,3,4] 티아디아진 8을 통하여 3-아미노-2-페닐이미노-1,3-티아졸린 유도체 2(195종)의 집중 라이브러리를 구축하였다.

Importance of Silicon Atom in the Drug Design Process

  • Gadhe, Changdev G.;Cho, Seung Joo
    • 통합자연과학논문집
    • /
    • 제5권4호
    • /
    • pp.229-232
    • /
    • 2012
  • The pharmaceutical industry has an ongoing need for new, safe medicines with genuine biomedical effects. Most of the candidate molecules are far from becomes a drug, because of their pharmacokinetic and pharmacodynamic properties. The introduction of bioisostere to improve properties of molecules and to obtain new class of compound is currently increased. Silicon substitution of carbon of existing drugs is an attractive strategy to search a new candidate with improved biological and physicochemical properties. The fundamental differences between carbon and silicon can lead to improved profile of the silicon containing candidate, and could be exploited to get further benefit in drug design process.